Palavras-chave
leucemia linfoide aguda
tratamiento
bisfosfonato
anticuerpo monoclonal
Como Citar
Resumo
La osteonecrosis es una causa de dolor articular y deformidad, generalmente, causada por trauma. La osteonecrosis no traumática es otra forma de presentación de dicha patología y mayormente asociada al uso de corticoides. Se hizo una revisión de la literatura en cuanto al manejo de los pacientes en quienes cursa dicha patología, en los que se evidencian manejo conservadores dados por seguimiento, inmovilización o manejos quirúrgicos, como core decompresion, reemplazos articulares o artrodesis. En muy pocos artículos se encuentra evidencia de manejo con bisfosfonatos, en especial con ácido ibandrónico, para el manejo sintomático de dicha patología secundaria al uso de corticoide en pacientes con leucemia linfoide aguda. No hay reportes en la literatura acerca del uso de anticuerpos monoclonales para el manejo de pacientes con osteonecrosis, utilizados en mujeres con osteoporosis inducida por menopausia.
Brooker BJ, Keith PPA. Osteonecrosis: The perils of steroids. A review of the literature and case report. Case Reports in Clinical Medicine. 2012;1(2):26-37.
Padhye B, Dalla-Pozza L, Little D, Munns C. Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: A retrospective analysis. Pediatr Blood Cancer. 2013;60:1539-45.
Saini A, Saifuddin A. MRI of osteonecrosis. Clin Radiol. 2004;59:1079-93.
Murphy RG, Greenberg ML. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia. Cancer. 1990;65:1717-21.
Solarino G, Scialpi L, Bruno N, De Cillis B. On a case of multifocal osteonecrosis in a patient suffering from acute lymphoblastic leukemia. Chir Organi Mov. 2008;92:119-22.
Mont MA, LaPorte D, Jones LC. Symptomatic multifocal osteonecrosis: A multicenter study. Collaborative Osteonecrosis Group. Clin Orthop Relat Res. 1999;369:312-26.
Mattano LA Jr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of trating acute lymphoblastic leukemia in children: A report from the Children´s Cancer Group. J Clin Oncol. 2000;18:3262-72.
Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: Ten years later. J Bone Joint Surg. 2006;88:1117-32.
Atsumi T, Kuroki Y. Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin Orthop Relat Res. 1992;277:22-30.
Sala A, Mattano LA Jr, Barr RD. Osteonecrosis in children and adolescents with cancer-An adverse effect of systemic therapy. Eur J Cancer. 2007;43:683-9.
Ojala AE, Paakko E, Lanning FP, Lanning M. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: A prospective MRI study. Med Pediatr Oncol. 1999;32:11-7.
Aricò M, Boccalatte MF, Silvestri D et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica. 2003;88:747-53.
Wei SY, Esmail AN, Bunin N, Dormans JP. Avascular necrosis in children with acute lymphoblastic leukemia. J Pediatr Orthop. 2000;20:331-5.
Raab P, Kuhl J, Krauspe R. Multifocal osteonecrosis in children and adolescents after polychemotherapy. Z Orthop Ihre Grenzgeb. 1997;135:444-50.
Silverman SL. Bisphosphonate use in conditions other than osteoporosis. Ann NY Acad Sci. 2011;1218:33-7.
Weinstein RS. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin North Am. 2012;41(3):595-611.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.